Finland· FI-REL-REL37614
Rasitrio
A aliskiren, amlodipine and hydrochlorothiazide product containing aliskiren hemifumarate + amlodipine besylate + hydrochlorothiazide, registered in Finland by Novartis Europharm Ltd.
Checked against Fimea (Finland) on
Informational only — not a medical device.
The record
At a glance
Fimea (Finland)- Active substance
- Aliskiren hemifumarate + Amlodipine besylate + Hydrochlorothiazide
- Manufacturer
- Novartis Europharm Ltd
- Country
- Finland (FI)
- ATC code
- C09XA54
- ATC class
- Aliskiren, amlodipine and hydrochlorothiazide
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
54 interactions on record for aliskiren, amlodipine and hydrochlorothiazide.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aliskiren, amlodipine and hydrochlorothiazide · interactions on record
54 records
54 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09XA54
Aliskiren, amlodipine and hydrochlorothiazide, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc2951d5-494a-4311-97a7-7bbd953dc806 GET /v1/drugs/bc2951d5-494a-4311-97a7-7bbd953dc806?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": null,
"strength": "300 mg / 10 mg / 12.5 mg",
"atc_label": "aliskireeni, amlodipiini ja hydroklooritiatsidi",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/11/730/037-048",
"fimea_rel_id": "REL37614",
"authorised_at": "2011-11-22"
}See everything about aliskiren, amlodipine and hydrochlorothiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.